Leukemia - Table of Contents alert Volume 30 Issue 12

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 30, Issue 12 (December 2016) In this issue Reviews Original Articles Letters to the Editor Corrigendum Also new AOP Advertisement Oncogenesis is an online-only, open access journal exploring the molecular basis of cancer and related phenomena. The journal seeks to promote diverse and integrated areas of molecular biology, cell biology, oncology, and genetics. Explore the benefits of submitting your next research article. Sign up for e-alerts Recommend to your library Web feed Follow on Twitter Subscribe Advertisement Blood Cancer Journal is an online-only, open access journal, publishing high quality research on hematologic malignancies and related disorders. Explore the benefits of submitting your next research article. Reviews Top Human memory B cells M Seifert and R Küppers Leukemia 2016 30: 2283-2292; advance online publication, August 8, 2016; 10.1038/leu.2016.226 Abstract | Full Text B cells and macrophages pursue a common path toward the development and progression of chronic lymphocytic leukemia G Galletti, F Caligaris-Cappio and M T S Bertilaccio Leukemia 2016 30: 2293-2301; advance online publication, September 28, 2016; 10.1038/leu.2016.261 Abstract | Full Text Original Articles Top ACUTE MYELOID LEUKEMIA Small molecule inhibition of cAMP response element binding protein in human acute myeloid leukemia cells B Mitton, H -D Chae, K Hsu, R Dutta, G Aldana-Masangkay, R Ferrari, K Davis, B C Tiu, A Kaul, N Lacayo, G Dahl, F Xie, B X Li, M R Breese, E M Landaw, G Nolan, M Pellegrini, S Romanov, X Xiao and K M Sakamoto Leukemia 2016 30: 2302-2311; advance online publication, May 23, 2016; 10.1038/leu.2016.139 Abstract | Full Text ACUTE LYMPHOBLASTIC LEUKEMIA Eye on the B-ALL: B-cell receptor repertoires reveal persistence of numerous B-lymphoblastic leukemia subclones from diagnosis to relapse OPEN R J M Bashford-Rogers, K A Nicolaou, J Bartram, N J Goulden, L Loizou, L Koumas, J Chi, M Hubank, P Kellam, P A Costeas and G S Vassiliou Leukemia 2016 30: 2312-2321; advance online publication, May 23, 2016; 10.1038/leu.2016.142 Abstract | Full Text MYELODYSPLASTIC SYNDROME Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1-mutant myelodysplastic syndromes OPEN H Dolatshad, A Pellagatti, F G Liberante, M Llorian, E Repapi, V Steeples, S Roy, L Scifo, R N Armstrong, J Shaw, B H Yip, S Killick, R Kušec, S Taylor, K I Mills, K I Savage, C W J Smith and J Boultwood Leukemia 2016 30: 2322-2331; advance online publication, May 23, 2016; 10.1038/leu.2016.149 Abstract | Full Text CHRONIC MYELOPROLIFERATIVE NEOPLASMS JAK2V617F-mutant megakaryocytes contribute to hematopoietic stem/progenitor cell expansion in a model of murine myeloproliferation H Zhan, Y Ma, C H S Lin and K Kaushansky Leukemia 2016 30: 2332-2341; advance online publication, May 2, 2016; 10.1038/leu.2016.114 Abstract | Full Text Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis M Jawhar, J Schwaab, D Hausmann, J Clemens, N Naumann, T Henzler, H-P Horny, K Sotlar, S O Schoenberg, N C P Cross, A Fabarius, W-K Hofmann, P Valent, G Metzgeroth and A Reiter Leukemia 2016 30: 2342-2350; advance online publication, July 15, 2016; 10.1038/leu.2016.190 Abstract | Full Text MOLECULAR TARGETS FOR THERAPY Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo P Storti, V Marchica, I Airoldi, G Donofrio, E Fiorini, V Ferri, D Guasco, K Todoerti, R Silbermann, J L Anderson, W Zhao, L Agnelli, M Bolzoni, E Martella, C Mancini, N Campanini, D M Noonan, P G Petronini, A Neri, F Aversa, G D Roodman and N Giuliani Leukemia 2016 30: 2351-2363; advance online publication, May 20, 2016; 10.1038/leu.2016.137 Abstract | Full Text EARLY PHASE STUDIES Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignancies Z A Hing, H Y J Fung, P Ranganathan, S Mitchell, D El-Gamal, J A Woyach, K Williams, V M Goettl, J Smith, X Yu, X Meng, Q Sun, T Cagatay, A M Lehman, D M Lucas, E Baloglu, S Shacham, M G Kauffman, J C Byrd, Y M Chook, R Garzon and R Lapalombella Leukemia 2016 30: 2364-2372; advance online publication, May 20, 2016; 10.1038/leu.2016.136 Abstract | Full Text CYTOGENETICS AND MOLECULAR GENETICS Loss of Dnmt3b accelerates MLL-AF9 leukemia progression Y Zheng, H Zhang, Y Wang, X Li, P Lu, F Dong, Y Pang, S Ma, H Cheng, S Hao, F Tang, W Yuan, X Zhang and T Cheng Leukemia 2016 30: 2373-2384; advance online publication, May 2, 2016; 10.1038/leu.2016.112 Abstract | Full Text Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis D Juskevicius, T Lorber, J Gsponer, V Perrina, C Ruiz, F Stenner-Liewen, S Dirnhofer and A Tzankov Leukemia 2016 30: 2385-2395; advance online publication, May 20, 2016; 10.1038/leu.2016.135 Abstract | Full Text Letters to the Editor Top Chronic myeloid leukemia patients call for quality and consistency when generics are introduced to treat their cancer OPEN J Geissler, G Sharf, J Cugurovic, R Padua, Š Narbutas, M Remic and V Venkatesh for the CML Advocates Network Leukemia 2016 30: 2396-2397; advance online publication, August 3, 2016; 10.1038/leu.2016.220 Full Text Anti-CD44 antibodies inhibit both mTORC1 and mTORC2: a new rationale supporting CD44-induced AML differentiation therapy OPEN S Z Gadhoum, N Y Madhoun, A F Abuelela and J S Merzaban Leukemia 2016 30: 2397-2401; advance online publication, August 8, 2016; 10.1038/leu.2016.221 Full Text The novel PI3K-δ inhibitor TGR-1202 enhances Brentuximab Vedotin-induced Hodgkin lymphoma cell death via mitotic arrest S L Locatelli, G Careddu, G Inghirami, L Castagna, P Sportelli, A Santoro and C Carlo-Stella Leukemia 2016 30: 2402-2405; advance online publication, August 8, 2016; 10.1038/leu.2016.224 Full Text Molecular predictors of response in patients with myeloid neoplasms treated with lenalidomide E Negoro, T Radivoyevitch, C Polprasert, V Adema, N Hosono, H Makishima, B Przychodzen, C Hirsch, M J Clemente, A Nazha, V Santini, K L McGraw, A F List, F Sole, M A Sekeres and J P Maciejewski Leukemia 2016 30: 2405-2409; advance online publication, August 18, 2016; 10.1038/leu.2016.228 Full Text Dissection of CD20 regulation in lymphoma using RNAi M Słabicki, K S Lee, A Jethwa, L Sellner, F Sacco, T Walther, J Hüllein, S Dietrich, B Wu, D B Lipka, C C Oakes, S Mamidi, B Pyrzyńska, M Winiarska, M Oleś, M Seifert, C Plass, M Kirschfink, M Boettcher, J Gołąb, W Huber, S Fröhling and T Zenz Leukemia 2016 30: 2409-2412; advance online publication, August 18, 2016; 10.1038/leu.2016.230 Full Text The CALR exon 9 mutations are shared neoantigens in patients with CALR mutant chronic myeloproliferative neoplasms M O Holmström, C H Riley, I M Svane, H C Hasselbalch and M H Andersen Leukemia 2016 30: 2413-2416; advance online publication, August 18, 2016; 10.1038/leu.2016.233 Full Text Toll-like receptor signaling-deficient mice are easy mobilizers: evidence that TLR signaling prevents mobilization of hematopoietic stem/progenitor cells in HO-1-dependent manner OPEN M Adamiak, A Abdelbaset-Ismail, M Kucia, J Ratajczak and M Z Ratajczak Leukemia 2016 30: 2416-2419; advance online publication, August 18, 2016; 10.1038/leu.2016.236 Full Text Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients OPEN S Mimmi, E Vecchio, E Iaccino, M Rossi, A Lupia, F Albano, F Chiurazzi, G Fiume, A Pisano, S Ceglia, M Pontoriero, G Golino, P Tassone, I Quinto, G Scala and C Palmieri Leukemia 2016 30: 2419-2422; advance online publication, August 29, 2016; 10.1038/leu.2016.245 Full Text Targeted sequencing informs the evaluation of normal karyotype cytopenic patients for low-grade myelodysplastic syndrome E J Duncavage, J O'Brien, K Vij, C A Miller, G S Chang, J Shao, M A Jacoby, S Heath, M R Janke, K Elliott, R S Fulton, C Fronick, M O'Laughlin, P Westervelt, T J Ley, R K Wilson and M J Walter Leukemia 2016 30: 2422-2426; advance online publication, August 30, 2016; 10.1038/leu.2016.247 Full Text Allogeneic hematopoietic cell transplantation with double alkylating agents containing reduced-intensity conditioning for patients ≥60 years with advanced AML/MDS H Bertz, M Lübbert, K Ohneberg, R Zeiser, R Wäsch, R Marks and J Finke Leukemia 2016 30: 2426-2429; advance online publication, August 30, 2016; 10.1038/leu.2016.248 Full Text Corrigendum Top Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia V Madan, P Shyamsunder, L Han, A Mayakonda, Y Nagata, J Sundaresan, D Kanojia, K Yoshida, S Ganesan, N Hattori, N Fulton, K T Tan, T Alpermann, M C Kuo, S Rostami, J Matthews, M Sanada, L-Z Liu, Y Shiraishi, S Miyano, E Chendamarai, H A Hou, G Malnassy, T Ma, M Garg, L W Ding, Q Y Sun, W Chien, T Ikezoe, M Lill, A Biondi, R A Larson, B L Powell, M Lübbert, W J Chng, H F Tien, M Heuser, A Ganser, M Koren-Michowitz, S M Kornblau, H M Kantarjian, D Nowak, W K Hofmann, H Yang, W Stock, A Ghavamzadeh, K Alimoghaddam, T Haferlach, S Ogawa, L Y Shih, V Mathews and H P Koeffler Leukemia 2016 30: 2430; advance online publication, October 7, 2016; 10.1038/leu.2016.237 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Leukemia. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.